Kolon TissueGene Decides on 47.8 Billion KRW Paid-in Capital Increase
Kolon TissueGene announced on the 23rd that it has decided to conduct a paid-in capital increase worth 47.8 billion KRW to secure operating funds.
The company will issue 762,350 common shares at 62,460 KRW per share through a third-party allotment. The third-party allotment target is Kolon Co., Ltd., the largest shareholder.
Hot Picks Today
“We Have One in Every Home”… Samsung Air Conditioners Become ‘Luxury Items’ Amid Europe’s Heatwave
- "Found the Culprit Behind Wild Swings"... The Truth Behind 'Delta' Shaking the Stock Market [Weekend Money]
- "KOSPI to Hit 12,600"... Top 10 Preferred Stocks in the Bullish Second Half [Weekend Money]
- "Turning Off the Air Conditioner Can Be Dangerous"...Heart Strain Increases When Bedroom Temperature Exceeds 24 Degrees Celsius
- "Once Called a History-Changing Group"... Rise of Cortis Spurs Revaluation of Entertainment Stocks [Weekend Money]
Regarding the selection process, the company stated, "The allocation was made considering the investor's intention and payment capability to achieve management objectives and raise funds."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
![Foreign Investors Sell Off, Yen Plummets... 'Partner' Won Also Faces Greater Downward Pressure [Weekend Money]](https://cwcontent.asiae.co.kr/asiaresize/307/2026070215192532285_1782973165.jpg)
